Broadcom (AVGO) Analyst Price Targets vs. Fundamental Analysis

AVGO analyst price targets see 34% upside from a 4-of-4 compounder trading 25% off its high

By Mathew Auto

Data as of July 8, 2026.

AVGO analyst price targets average $497, implying 34% upside from a stock that has pulled back 25% from its 52-week high. The business underneath that pullback is the cleanest compounder in large-cap semiconductors right now. Revenue grew 48% last year, the operating margin runs at 49%, and free cash flow comes in at 36% of revenue. The tension in Broadcom isn’t whether the business is good. It’s whether the 61x earnings multiple and the weakening chart structure leave enough room for 28 largely bullish analysts to be right on the timing.

What Analysts Say About AVGO

Coverage on AVGO is near-unanimous. Twenty-eight analysts have current price targets, and 94.5% of them are at Buy. The remaining 5.5% are at Hold. No Sells. The average AVGO analyst price target is $496.77, against a current price of $371, which works out to 34% implied upside. The PT range runs from $380 at the low to $582 at the high, a $202 spread. That gap reflects the distance between the most cautious and most aggressive bullish views in the coverage.

The most recent updates held or raised targets rather than trimming them. Timothy Arcuri at UBS raised his target from $475 to $485 in early June. Blayne Curtis at Jefferies and William Stein at Truist both hold $550 targets. Mizuho issued a Buy at $530 among the latest actions. At the higher end, Cody Acree at Benchmark carries a $545 target, implying 47% upside from current levels. The direction of recent revisions has been upward. No desk has moved to Sell as the stock pulled back from its highs.

In fact, the overall hit ratio across analysts covering AVGO is 93.58%, with targets taking 266 days on average to be reached. That’s a notably high collective track record on a single name. AVGO analyst price targets aren’t set by analysts with patchy records. The coverage pool here has historically followed through at a rate that puts this name near the top of large-cap tech by hit consistency.

What the Fundamentals Show

investlyk’s fundamental scorecard for Broadcom (investlyk.com →) rates the business 4 of 4 strong across all four financial health signals: scalable growth, cash-backed profits, comfortable debt coverage, and compounding equity. Broadcom is one of only a handful of names in large-cap tech that scores a clean sweep on all four.

The growth signal earns its mark clearly. Revenue grew 47.9% year over year. Two tailwinds drove it: AI custom accelerator and networking chip demand from hyperscalers, plus the VMware acquisition scaling its enterprise software revenue. Both businesses run at high margins. The operating margin reached 49%, the free-cash-flow margin came in at 36.1%, and return on invested capital was 37.3%. These aren’t stretched numbers from a single good quarter. They reflect a business converting an expanding revenue base into cash at an unusually consistent rate.

The cautious flags in the scorecard are price and timing, not the underlying business. At 61x trailing earnings, valuation scores “Caution” on the investlyk framework. The stock is 25% below its 52-week high with declining highs and lows, short-term momentum still under pressure, and timing reading 1 of 3 supportive. The valuation scorecard comes in at 2 of 4, which is a reasonable flag at a 61x multiple even for a compounder of this quality. What the scorecard signals: price and timing don’t yet confirm the pullback has found its floor. That’s separate from whether the business itself warrants a long position.

Where the Gap Is, and What Would Close It

The analyst consensus and the investlyk scorecard broadly agree on what Broadcom is: a cash-generating compounder with structural advantages in AI silicon and enterprise software. The disagreement is on price and timing. At $371 and 61x trailing earnings, the stock embeds strong growth expectations. For the average AVGO analyst price targets of $497 to be reached, the stock needs to rally 34% from here.

So that closes one of two ways. Either the multiple stays elevated while earnings grow into it, or earnings grow fast enough to compress the multiple and the stock follows. Given that revenue grew 48% last year, if earnings expand at even half that pace over the next 12 to 18 months, the trailing P/E could fall to 45 to 50x at the current price. That’s still a premium multiple, but more defensible for a business with 36% free-cash-flow margins and a recurring VMware software stream. So the path to $497 doesn’t require a re-rating upward; it requires the earnings growth story to hold.

Still, the risk that keeps the gap open: a slowdown in AI capital spending from hyperscalers, which would hit Broadcom’s custom chip revenue before it touched the software base. VMware adds a recurring revenue floor that changes the downside case compared to a pure-chip business. But the stock’s current multiple is priced on growth. If the AI buildout cycle decelerates meaningfully in the next two quarters, analysts will likely cut targets, and the $497 average will move lower. That’s the scenario where the gap doesn’t close on the typical 266-day timeline.

Which Analyst Has the Best Track Record on AVGO?

Timothy Arcuri of UBS has hit 40 of 41 documented price targets on AVGO specifically, a 97.56% met ratio. His current target is $485 at Buy. After all, those are 41 calls on this one stock, not a career average spread across dozens of names. Forty of them were reached.

Blayne Curtis at Jefferies has hit 25 of 27 AVGO targets (92.59%) and currently holds a $550 Buy. William Stein at Truist is 30 of 34 (88.24%), also at $550. Joshua Buchalter at TD Cowen carries the highest individual performance score in the visible coverage with 7 of 9 targets met and a current Buy at $500. AnaChart also flags Atif Malik, Kevin Cassidy, Matthew Prisco, and Jim Kelleher among the top performers on Broadcom by long-term track record.

What is the current analyst price target for AVGO?

AVGO analyst price targets average $496.77, implying about 34% upside from the current price of $371. The 28 analysts covering Broadcom span a range from $380 at the low to $582 at the high. 94.5% of them hold a Buy rating, with no Sells anywhere in the current coverage.

Is AVGO a Buy or Sell according to analysts?

94.5% of the 28 analysts covering AVGO rate it a Buy, with the remaining 5.5% at Hold and no Sells. Recent updates have leaned upward, Desks including UBS, Jefferies, Truist, and Mizuho all maintained Buy ratings and held or raised targets as the stock pulled back.

How often are AVGO analyst price targets actually reached?

The average hit ratio across the 28 analysts covering AVGO is 93.58%, with targets taking about 266 days to be reached once issued. Timothy Arcuri of UBS leads on this stock with 40 of 41 AVGO targets met, a 97.56% rate. Blayne Curtis of Jefferies has reached 25 of 27 (92.59%), and William Stein of Truist is 30 of 34 (88.24%).

How does Broadcom’s fundamental scorecard compare to analyst targets?

investlyk’s 4-of-4 financial scorecard and the analyst consensus align well on business quality: both treat Broadcom as a cash-generating compounder with structural advantages in AI silicon and enterprise software. Where they diverge is valuation and timing. The scorecard flags 61x earnings as Caution and timing at only 1 of 3 supportive, while analysts are pricing in 34% upside from the current price. In short, the agreement is on what the business delivers. The question is whether the stock’s current valuation leaves room for AVGO analyst price targets to be reached on the typical 266-day timeline.

For a full view of analyst track records on AVGO, visit AnaChart’s AVGO coverage page or explore the analyst price target dataset.